Sunshine Biopharma Inc. Notes Payable
Sunshine Biopharma Inc. (SBFM) had Notes Payable of $0 as of 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2026-04-03
- 2025-12-31: Notes Payable $0.00.
- 2024-12-31: Notes Payable $0.00.
- 2022-12-31: Notes Payable $0.00.
- 2022-09-30: Notes Payable $0.00.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-04-03 | |
| 2024-12-31 | $0.00 10-K · filed 2026-04-03 | |
| 2022-12-31 | $0.00 10-K · filed 2023-04-04 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $1.90M 10-K · filed 2023-04-04 | |
| 2018-12-31 | $419.66K 10-K · filed 2019-04-12 | |
| 2017-12-31 | $596.58K 10-K · filed 2019-04-12 | |
| 2016-12-31 | $69.94K 10-K · filed 2018-04-02 | |
| 2015-12-31 | $102.14K 10-K · filed 2017-04-17 | $305.18K 10-K · filed 2016-03-25 |
| 2014-12-31 | $480.12K 10-K · filed 2016-03-25 | |
| 2013-12-31 | $12.50K 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |